Document is current
Any future updates will be listed below
-
Authors
Fleischmann, Roy M. http://orcid.org/0000-0002-6630-1477
Alvarez, Daniel F.
Bock, Amy E.
Cronenberger, Carol
Vranic, Ivana
Zhang, Wuyan
Alten, Rieke
-
Funding
Funding for this research was provided by:
Pfizer (not applicable)
- License Information
-
More Information
Article History
Received: 9 April 2021
Accepted: 12 September 2021
First Online: 25 September 2021
Declarations
:
: This study was conducted in compliance with the ethical principles originating in, or derived from, the Declaration of Helsinki and in compliance with all International Conference on Harmonisation Good Clinical Practice Guidelines. The study protocol, all amendments, and informed consent documentation were reviewed and approved by the Institutional Review Boards and/or Independent Ethics Committees. In addition, all local regulatory requirements were followed, in particular, those affording greater protection to the safety of trial participants. All patients provided informed consent before undergoing any screening procedures.
: Not applicable.
: DFA, AEB, and IV are full-time employees of, and declare shareholdings, stock holdings, and/or stock options from, Pfizer. CC was a full-time employee of Pfizer at the time of data generation and manuscript development and declares shareholdings, stock holdings, and/or stock options from Pfizer. WZ is a full-time employee of Pfizer and declares shareholdings, stock holdings, and/or stock options from Pfizer, AbbVie, and Abbott. RMF has received research grants/support and consulting fees from Pfizer. RA has received research grants/support and consulting fees from AbbVie, Bristol-Myers Squibb, Gilead, Lilly, Novartis, Pfizer, and UCB.
